Within eukaryotic cells, mitochondria grow and reproduce by incorporation of newly synthesized proteins and lipids into preexisting organelles (cf. 1). However, most mitochondrial proteins are synthesized in the cytoplasm (cf. 2), and it is not known how these proteins are transferred to their intramitochondrial destination. We have investigated the mechanism by which cytoplasmic polypeptides are selected for incorporation into the organelle, using rat liver cytochrome c as a model system.
Cytochrome c is a peripheral membrane protein found in the intermembrane compartment of mitochondria, where it transfers electrons between cytochrome c reductase and cytochrome c oxidase, both integral protein complexes of the inner mitochondrial membrane (3) . It is known that cytochrome c is coded for by a nuclear gene (4; cf. 5) and that the polypeptide is synthesized outside mitochondria on cytoplasmic ribosomes (6) (7) (8) (9) .
We found that treatment of rats with the thyroid hormone 3,3,5'-triiodo-L-thyronine (T3) increases the level of translatable cytochrome c mRNA in liver cells. This enabled the demonstration that in rat liver, as is the case in neurospora (9) , cytochrome c is synthesized on free ribosomes. Conditions were then developed for uptake of the in vitro synthesized cytochrome c by mitochondria, which allowed a characterization of structural elements of the molecule that participate in the mechanism mediating its translocation across the outer mitochondrial membrane.
MATERIALS AND METHODS
Albino male Sprague-Dawley rats (=150 g) received daily intraperitoneal injections of T3 (300 jig per 150-g rat) for 5 days.
Before sacrifice, 1 day after the last injection, animals were starved for 14-16 hr.
Free and membrane-bound polysomes (10) and total polysomes (11) were prepared by published procedures, and poly(A)+mRNA was isolated as described (12) .
In Vitro Protein Synthesis. Translation of mRNA (0.05 A2w unit/50 ,1u) was carried out in the reticulocyte lysate (13) for 1 hr at 28°C with 200 units of Trasylol (Mobay Chemical, New York) per ml as a protease inhibitor, and 50 ,uCi (1 Ci = 3.7 x 10'°becquerels) of [35S]methionine (800 Ci/mmol; Amersham) per 50 ,u1.
Preparation of Anti-Cytochrome c Antibodies. Mouse cytochrome c, which has the same amino acid sequence as rat cytochrome c (14) , was used to raise antisera in rabbits and separate total specific IgG by immunoabsorption, as described (15, 16) .
Chromatographic Separation of Cyanogen Bromide Fragments from Horse Apocytochrome c. Horse heart apocytochrome c (80 mg) was prepared (17) , subjected to CNBr fragmentation (18) , lyophilized, and dissolved in 1 ml of 10% (vol/ vol) formic acid. The sample was applied to a Bio-Gel P6 column
(1 x 100 cm) equilibrated and eluted with 10% formic acid.
Four fractions (I-IV) were recovered as distinct peaks containing polypeptide fragments, which were identified after dansylation ofNH2-terminal amino acids. Fraction I contained a 9:1 mixture offragments composed ofresidues 1-65/1-80; but fractions II, III, and IV contained single fragments composed of residues 66-104 (fragment II), 81-104 (fragment III), and 66-80 (fragment IV), respectively.
RESULTS
There is a well-established relation between thyroid hormone activity and the cellular concentration of cytochrome c; hyperthyroid rat tissues contain higher than normal levels and hypothyroid tissues contain lower than normal levels ofthe protein (19, 20) . Furthermore, administration of T3 to rats has been shown to lead to a rapid increase in the activity of respiratory enzymes in the liver (21 cific mRNAs for components of the mitochondrial electron transport chain may be induced by the thyroid hormone. Indeed, whereas with control mRNA the in vitro synthesis of cytochrome c was almost undetectable (Fig. la) , we found that with mRNA from T3-treated rats an immunoprecipitable polypeptide with the mobility of holocytochrome c (Fig. 1, lane b) represented 0.1% of the total incorporation. To determine the cytoplasmic site ofsynthesis ofcytochrome c, the products made under the direction of mRNAs from free and membrane-bound polysomes obtained from T3-treated rats were characterized. Two clearly different sets of polypeptides, which spanned a wide size range, were encoded by these mRNA preparations (Fig. 2, lanes a and b) , and analysis of immunoprecipitates demonstrated that the mRNA directing the synthesis of cytochrome c was largely confined to the free polysomes (Fig. 2, lanes c and e) .
It appears most likely that the segregation ofthe cytochrome c mRNA to the free polysomes ofT3-treated rats reflects a similar distribution in normal animals. Indeed, immunoprecipitates with anti-albumin antibodies showed that T3 treatment did not alter the normal distribution ofthe mRNA for this secretory protein, which is synthesized in bound polysomes (Fig. 2 , lanes d and f).
Previous work with neurospora (9) in vitro synthesized cytochrome c from neurospora (9), and DNA sequence determination of the yeast cytochrome c gene (23) have shown that, in these lower eukaryotes, cytochrome c is not synthesized as a higher molecular weight precursor. The similar mobilities in NaDodSO4 gels of the polypeptide synthesized in vitro and native rat liver cytochrome c (Fig. 2 , lanes c and g) suggested that this is also the case for vertebrates. This was confirmed by comparison of a partial NH2-terminal amino acid sequence of the polypeptide synthesized in vitro with the known sequence ofthe holoprotein (14) . Cytochrome c was synthesized in vitro in a translation mixture containing
[3S]methionine or [3H]lysine, or both, to which the acetyl trap, introduced by Palmiter (24) to prevent NH2-terminal acetylation, was added. It also became necessary to add a mixture of proteinase inhibitors [1 mM o-phenanthroline, L-leucyl-L-leucyl-L-leucine (0.5 mg/ml) and pepstatin (0.2 mg/ml)], because in their absence the in vitro synthesized, nonacetylated, labeled cytochrome c was rapidly and almost completely degraded to nonimmunoprecipitable products (Fig. 1, lanes c and d) . Be release into the cell sap. Therefore, the capacity of isolated mitochondria to accept the in vitro product was investigated. Labeled polypeptides were synthesized in vitro in translation mixtures programmed with free polysomal messenger RNA. A suspension of isolated rat liver mitochondria was then added together with cycloheximide to ensure that any uptake of labeled polypeptides into mitochondria in the ensuing 1-hr incubation did not involve a cotranslational mechanism. It was found that, during the incubation after translation, almost all (-90%, as estimated from densitometric tracings) of the newly synthesized cytochrome c became associated with the sedimentable mitochondria (Fig. 4 , lane c) and resistant to digestion by exogeneously added trypsin (Fig. 4, lane d) . Thus, cytochrome c did not remain exposed on the mitochondrial outer membrane but probably was transferred to its normal intermembrane destination, where it was protected from the protease. Because under similar conditions labeled preproalbumin failed to bind to mitochondria (Fig. 4 for 60 min in the presence of cycloheximide (10 mM) and chymostatin (1 mg/ml) with intact mitochondria (3 mg ofmitochondrial protein per ml of mixture) prepared from the livers of unstarved rats as described (26) translation is a specific property of mitochondrial outer membranes.
To determine the configuration of the molecule that participates in the posttranslational uptake by mitochondria, the capacity of holo-and apo-cytochrome c to compete with the in vitro synthesized peptide for uptake by mitochondria was examined. It was found that whereas apocytochrome c almost completely inhibited uptake ofthe in vitro product (Fig. 5, lane 0, an excess ofholocytochrome did not prevent the transfer into mitochondria (Fig. 5, lane e) . Moreover, as expected from the results of these competition experiments, "2I-labeled holocytochrome c failed to bind to mitochondria (Fig. 5, lane g ). These observations suggest that the conformation of the newly synthesized product is functionally equivalent to that of apocytochrome c and, therefore, that conversion to the holocytochrome occurs after the newly synthesized polypeptide is transferred into the mitochondrion. A similar conclusion has been reached by Korb and Neupert (29) , who studied the biosynthesis of cytochrome c in neurospora using antibodies specific for the apo and holo forms of the protein.
Inhibition approximately molar ratios of added holocytochrome c to in vitro synthesized product of 2600:1 and of added apocytochrome c to in vitro synthesis product of 3200:1. After the posttranslational incubation, the mitochondria or other added membranes were reisolated by centrifugation. Resuspended sediments (i) and supernatant (s) were analyzed as described in the legends to Figs. 4 and 1. A high concentration of antibody (90 Mug) was used to recover the in vitro product, which in the presence of apocytochrome (lanef) remained in the supernatant after incubation with mitochondria. mRNA and radioactive methionine were not added to the translation mixture analyzed in lane g, which received '251-labeled holocytochrome c and mitochondria. taining holoprotein. To determine if a specific segment of the polypeptide plays a role in mitochondrial recognition, fragments produced by cyanogen bromide treatment of apocytochrome c were separated and used for competition with the in vitro synthesized product.
Cytochrome c contains methionyl residues at positions 65 and 80 (14) ; therefore, incomplete cleavage resulting from cyanogen bromide treatment generates five peptide fragments. Separation of the products by gel filtration yielded four fractions that were identified from their amino acid compositions.
Measurements of the uptake of labeled cytochrome c synthesized in vitro in the presence of these polypeptide fragments (Fig. 6, lanes a-g) showed that only a carboxyl-terminal segment composed of residues 66-104 (fragment II) and no other (not even the subfragments of that segment) was able to compete with the in vitro product and to prevent its incorporation into mitochondria (Fig. 6, lane g ).
DISCUSSION
The finding that rat liver cytochrome c is synthesized by free polysomes indicates that the completed polypeptide must be released into the cell sap before it is incorporated into the mitochondrion. This mechanism is consistent with our demonstration that isolated mitochondria have the capacity to take up the cytochrome c synthesized in vitro and protect it from attack by added trypsin, whereas other subcellular membranes do not take up the polypeptide. On the other hand, the mitochondria do not protect or bind preproalbumin, synthesized in the same system, or "2I-labeled holocytochrome c added after translation. Thus, the incorporation of cytochrome c is mediated by a mechanism that recognizes structural features characteristic of the newly synthesized molecule. The failure of mitochondria to take up or to bind the holocytochrome while incorporating the in vitro product suggests that heme binding and folding into the final spatial structure occur after or while the polypeptide is transferred across the outer mitochondrial membrane into the intermembrane space. A similar conclusion was reached by Neupert and his associates (29) , who have studied the biosynthesis of cytochrome c in neurospora and demonstrated the existence of a cytoplasmic pool of newly synthesized apocytochrome c, from which molecules labeled in vivo (7) or in a cellfree homogenate (8) can be chased into mitochondria.
An outer-membrane localization for putative receptors involved in the recognition of cytochrome c and possibly other polypeptides destined to the mitochondria is also suggested by our observations (unpublished data) that mild trypsinization of mitochondria abolishes their capacity for uptake. Furthermore, mitoplasts, which lack the outer mitochondrial membrane, were found to be incapable of any significant uptake of the product synthesized in vitro, although they were able to bind substantial amounts of "MI-labeled holocytochrome c.
In contrast to other mitochondrial (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) or chloroplast (41) (42) (43) (44) proteins that are synthesized in the cytoplasm, cytochrome c is not derived from a higher molecular weight precursor from which a peptide segment is removed proteolytically upon transfer of the polypeptide to its destination. Only one amino acid, the initiator methionine, is cleaved from the primary translation product, which is then acetylated at the adjacent glycine residue. However, these modifications, which take place in vitro in the absence of mitochondria and, therefore, are likely to occur in the cytoplasm, do not appear to be required for the uptake by mitochondria. Indeed, this was equally effective when methionine removal and acetylation had been prevented by carrying out synthesis of the polypeptide in the presence ofa mixture of proteinase inhibitors and an acetyl-consuming trap.
Several observations suggest that the structural features of cytochrome c, which are recognized by the outer mitochondrial Cell Biology: Matsuura et al.
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membrane and which may be considered its "addressing signal," are contained in a definite segment of its amino acid sequence and are masked in the holoprotein in its normal native conformation. Although addition of holocytochrome to the in vitro system did not affect the uptake of the in vitro product, removal of the heme allowed expression of the latent "addressing signal" because the apocytochrome effectively inhibited and, at sufficiently high concentration, completely prevented the uptake of the in vitro product. The signal appeared to be contained in a segment (fragment II) that encompasses the evolutionarily most highly conserved region of the cytochrome sequence, residues 70-80 (45, 46) and that in the native holoprotein is bound to the heme iron by the axial ligand, methionine-80 (47) . Indeed, there is no obvious species specificity in the signal-like activity of fragment II. The fragment derived from horse heart cytochrome c was used to compete with the rat in vitro product, and we have recently demonstrated that equivalent fragments from rabbit heart or yeast cytochromes c are also effective competitors. The capacity of fragment II to compete was markedly diminished by cleavage at methionine-80 into two subfragments (fragments III and IV), indicating that direct primary continuity of the polypeptide through that residue is required for expression of the configuration recognized by the mitochondrial receptors.
It may be noted that in the competition experiments described in this paper, whether carried out with the apoprotein or the CNBr fragment, large molar excess ofcompeting peptide over apoprotein synthesized in vitro (1000-to 10,000-fold, depending on the actual specific activity of the in vitro product) were used to show over 90% inhibition ofuptake. The specificity of the competition, however, is apparent from the fact that at the same concentrations the holocytochrome and fragments of the apocytochrome other than fragment II showed no demonstratable competing activity.
Clearly, several intriguing possibilities must be considered concerning the uptake mechanism and the features of fragment II that may serve as addressing signals for cytochrome c. It would be of interest, for example, to determine if fragment II prevents the uptake of other mitochondrial proteins of cytoplasmic origin and if these contain, transiently or permanently, structural similarities to fragment II. This may be expected if only a limited number of receptors exist in the mitochondrial surface that are recognized by families ofmitochondrial proteins with similar suborganellar destinations. From a biogenetic standpoint, the processing reaction that binds heme to cytochrome c may be regarded as functionally equivalent to the proteolytic cleavage that affects the cytoplasmic precursors of other mitochondrial proteins. In both cases, a posttranslational modification results in a change in the conformation of the polypeptide, from that conformation which is released from the ribosome and expresses an addressing signal in the cytoplasm to that which functions within the organelle.
